UTHR FY 2015 Earnings — United Therapeutics Corporation Revenue & Financial Results | Market Cap Arena

UTHRUnited Therapeutics Corporation

$24B

FY 2015 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$1.5B+13.8% YoY

Gross Profit

$1.4B95.3% margin

Operating Income

$699M47.7% margin

Net Income

$652M44.5% margin

EPS (Diluted)

$12.72

Cash Flow

Operating Cash Flow

$383M

Free Cash Flow

$333M

Stock-Based Comp.

$280M

Balance Sheet

Total Assets

$2.2B

Total Liabilities

$585M

Stockholders' Equity

$1.6B

Cash & Equivalents

$832M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$1.5B	$1.3B	+13.8%
Gross Profit	$1.4B	$1.2B	+20.1%
Operating Income	$699M	$539M	+29.7%
Net Income	$652M	$340M	+91.6%